DN
Therapeutic Areas
Manhattan Biosolutions Pipeline
| Drug | Indication | Phase |
|---|---|---|
| FGFR4-Targeted ADC | Cancer | Pre-clinical |
| Legumain-Cleavable TOP1i ADC | Cancer | Pre-clinical |
| TxD (Taxoid) ADC | Cancer | Pre-clinical |
| Pritumumab ADC | Cancer | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| FGFR4-Targeted ADC | Cancer | Pre-clinical |
| Legumain-Cleavable TOP1i ADC | Cancer | Pre-clinical |
| TxD (Taxoid) ADC | Cancer | Pre-clinical |
| Pritumumab ADC | Cancer | Pre-clinical |